Genomic Testing Cooperative (GTC) today highlighted its Liquid Trace® cerebrospinal fluid (CSF)-based molecular profiling ...
The global effort to develop a rapid antigen test for the Bundibugyo Ebola virus has identified five potential manufacturers, ...
Today, the World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL).
Today, the World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its ...
The rarity of sarcoma complicates clinical trial design and biomarker-driven treatment, explains Alexander Spira, MD, PhD, ...
Today, the World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its ...
Imagine diagnosing cancer, tracking its progress, and identifying treatment resistance—all from a simple blood sample. Just a ...
Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.
For Q2, according to Seeking Alpha, analysts are expecting normalized EPS of $1.28, GAAP EPS of $0.97, and $12.52bn of ...
Inside a small laboratory at the University Teaching Hospital in Lusaka, the capital of Zambia, a technician splits a sputum sample in two. Half goes into a GeneXpert machine, the workhorse of ...
Findings from 14 studies involving more than 8,000 patients show Prolaris adds insight beyond conventional clinical risk categories ...
India's cancer care is advancing with precision therapies and immunotherapy, but high costs, unequal access, limited diagnostics and insurance leave millions behind, highlighting the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results